Literature DB >> 20510718

Reoperation for recurrent/persistent well-differentiated thyroid cancer.

Sara I Pai1, Ralph P Tufano.   

Abstract

Reoperative surgery in the neck for recurrent/persistent well-differentiated thyroid cancer is associated with increased morbidity compared with primary surgery. Reoperative surgery is technically more challenging because of the presence of scar tissue and disruption of the normal fascial planes and anatomy, which may result in a greater risk of injury to nerves and other vital structures. When performing reoperative surgery, an algorithm should be followed that allows for safe and effective removal of recurrent/persistent disease. This algorithm should include a systematic review of prior operative and pathology notes, imaging studies appropriate for localization of disease, an understanding of reoperative central and lateral neck anatomy, along with an appreciation for disease behavior. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20510718     DOI: 10.1016/j.otc.2010.02.004

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN: 0030-6665            Impact factor:   3.346


  4 in total

1.  Radioguided occult lesion localization in patients with recurrent thyroid cancer.

Authors:  Murat Tuncel; Nilda Süslü
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-03-18       Impact factor: 2.503

Review 2.  Preoperative information for thyroid surgery.

Authors:  Vaninder K Dhillon; Jonathon O Russell; Mai G Al Khadem; Ralph P Tufano
Journal:  Gland Surg       Date:  2017-10

3.  Upregulation of the signal transducers and activators of transcription 3 (STAT3) pathway in lymphatic metastases of papillary thyroid cancer.

Authors:  Jingdong Zhang; Anthony Gill; Bryn Atmore; Amber Johns; Leigh Delbridge; Raymond Lai; Todd McMullen
Journal:  Int J Clin Exp Pathol       Date:  2011-04-28

4.  GAUGING THE EXTENT OF THYROIDECTOMY FOR INDETERMINATE THYROID NODULES: AN ONCOLOGIC PERSPECTIVE.

Authors:  David F Schneider; Linda M Cherney Stafford; Nicole Brys; Caprice C Greenberg; Courtney J Balentine; Dawn M Elfenbein; Susan C Pitt
Journal:  Endocr Pract       Date:  2017-01-17       Impact factor: 3.443

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.